Horizon Therapeutics Public Ltd Co Increase (Decrease) in Royalties Payable
Horizon Therapeutics Public Ltd Co reported Increase (Decrease) in Royalties Payable of -$3.38 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRoyaltiesPayable · last filed 2019-02-27
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for the quarter ending 2018-12-31 was -$1.23M, a 107.73% decline year-over-year.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for the quarter ending 2018-09-30 was $0.00.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for the quarter ending 2018-06-30 was $0.00.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for the quarter ending 2018-03-31 was -$2.15M.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for fiscal 2018 was -$3.38M, a 126.02% decline from fiscal 2017.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for fiscal 2017 was $13.00M.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for fiscal 2016 was -$713.00K, a 103.37% decline from fiscal 2015.
- Horizon Therapeutics Public Ltd Co increase (decrease) in royalties payable for fiscal 2015 was $21.15M, a 98.41% increase from fiscal 2014.
| Period end | Increase (Decrease) in Royalties Payable 3 month | Increase (Decrease) in Royalties Payable 6 month | Increase (Decrease) in Royalties Payable 9 month | Increase (Decrease) in Royalties Payable 12 month | Increase (Decrease) in Royalties Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$1.23M derived: sum of 2 quarters · filed 2019-02-27 | -$1.23M derived: sum of 3 quarters · filed 2019-02-27 | -$3.38M 10-K · filed 2019-02-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | -$2.15M 10-Q · filed 2018-11-07 | $13.80M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$2.15M 10-Q · filed 2018-08-08 | $13.80M derived: sum of 3 quarters · filed 2019-02-27 | $13.80M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-03-31 | -$2.15M 10-Q · filed 2018-05-09 | $13.80M derived: sum of 2 quarters · filed 2019-02-27 | $13.80M derived: sum of 3 quarters · filed 2019-02-27 | $13.80M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-12-31 | $15.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $15.95M derived: sum of 2 quarters · filed 2019-02-27 | $15.95M derived: sum of 3 quarters · filed 2019-02-27 | $13.00M 10-K · filed 2019-02-27 | $21.77M 10-K · filed 2018-02-28 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | -$2.94M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$2.94M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$2.94M 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | -$713.00K 10-K · filed 2019-02-27 | $386.00K 10-K · filed 2017-02-27 | |||
| 2015-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $6.87M derived: sum of 2 quarters · filed 2018-02-28 | $21.15M 10-K · filed 2018-02-28 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $14.28M 10-Q · filed 2016-11-07 | |||
| 2015-06-30 | $14.28M 10-Q · filed 2016-08-08 | ||||
| 2014-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$2.37M derived: sum of 2 quarters · filed 2017-02-27 | $10.66M 10-K · filed 2017-02-27 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $13.03M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $13.03M 10-Q · filed 2015-08-07 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 |